FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Nephron Sterile Compounding Center PF-Neostigmine Methylsulfate Injection Recall

PF-Neostigmine Methylsulfate Injection, USP 3 mg/3 mL (1 mg/mL) vial, Rx Only, Nephron…

Nephron Sterile Compounding Center LLC · West Columbia, SC

Risk level
Class II
Reported by FDA
Nov 23, 2022
Recall ID
D-0065-2023
Check your lot numberHow we source this data

Summary

Nephron Sterile Compounding Center recalled PF-Neostigmine Methylsulfate Injection starting Nov 10, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0065-2023 on Nov 23, 2022. Reason: CGMP Deviations: Potential for cross contamination due to product carry over. Status: Terminated.

Why it was recalled

CGMP Deviations: Potential for cross contamination due to product carry over.

Product description

PF-Neostigmine Methylsulfate Injection, USP 3 mg/3 mL (1 mg/mL) vial, Rx Only, Nephron 503B Outsourcing Facility 4500 12th Street Extension West Columbia, SC 29172, NDC 69374-932-33, UPC 3 69374-93233 2.

Lot numbers, UPCs & expiration codes

Lots: NE1062A, NE1062B Exp. 12/02/2022; NE1065A, NE1065B Exp. 12/13/2022; NE2011A, NE2011B Exp. 03/15/2022.

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0065-2023
Classification
Class II
Status
Terminated
Recall initiated
Nov 10, 2022
FDA report date
Nov 23, 2022
Quantity
56,220 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Nephron Sterile Compounding Center LLC

Original FDA data

Every field from FDA enforcement report D-0065-2023, exactly as published.

Show all FDA fields
City
West Columbia
State
SC
Status
Terminated
Country
United States
Event ID
91132
Address
4500 12th Street Ext
Code information
Lots: NE1062A, NE1062B Exp. 12/02/2022; NE1065A, NE1065B Exp. 12/13/2022; NE2011A, NE2011B Exp. 03/15/2022.
Postal code
29172-3025
Report date
Nov 23, 2022
Product type
Drugs
Recall number
D-0065-2023
Classification
Class II
Recalling firm
Nephron Sterile Compounding Center LLC
Product quantity
56,220 vials
Termination date
Sep 24, 2024
Reason for recall
CGMP Deviations: Potential for cross contamination due to product carry over.
Voluntary / mandated
Voluntary: Firm initiated
Product description
PF-Neostigmine Methylsulfate Injection, USP 3 mg/3 mL (1 mg/mL) vial, Rx Only, Nephron 503B Outsourcing Facility 4500 12th Street Extension West Columbia, SC 29172, NDC 69374-932-33, UPC 3 69374-93233 2.
Distribution pattern
Nationwide in the USA
Recall initiation date
Nov 10, 2022
Initial firm notification
Letter
Center classification date
Nov 17, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0065-2023, published Nov 23, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls